WO2015038796A3 - Secretion of heme-containing polypeptides - Google Patents

Secretion of heme-containing polypeptides Download PDF

Info

Publication number
WO2015038796A3
WO2015038796A3 PCT/US2014/055227 US2014055227W WO2015038796A3 WO 2015038796 A3 WO2015038796 A3 WO 2015038796A3 US 2014055227 W US2014055227 W US 2014055227W WO 2015038796 A3 WO2015038796 A3 WO 2015038796A3
Authority
WO
WIPO (PCT)
Prior art keywords
heme
secretion
containing polypeptides
polypeptides
containing
Prior art date
Application number
PCT/US2014/055227
Other languages
French (fr)
Other versions
WO2015038796A2 (en
Inventor
Rachel FRASER
Simon Christopher Davis
Patrick O'Rielly BROWN
Original Assignee
Impossible Foods Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201361876676P priority Critical
Priority to US61/876,676 priority
Priority to US201361908689P priority
Priority to US61/908,689 priority
Application filed by Impossible Foods Inc. filed Critical Impossible Foods Inc.
Priority claimed from US15/021,447 external-priority patent/US20160340411A1/en
Publication of WO2015038796A2 publication Critical patent/WO2015038796A2/en
Publication of WO2015038796A3 publication Critical patent/WO2015038796A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/22Working-up of proteins for foodstuffs by texturising
    • A23J3/225Texturised simulated foods with high protein content
    • A23J3/227Meat-like textured foods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/40Meat products; Meat meal; Preparation or treatment thereof containing additives
    • A23L13/42Additives other than enzymes or microorganisms in meat products or meat meals
    • A23L13/424Addition of non-meat animal protein material, e.g. blood, egg, dairy products, fish; Proteins from microorganisms, yeasts or fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Abstract

This disclosure provides for methods and compositions for the expression and secretion of heme-containing polypeptides.
PCT/US2014/055227 2013-09-11 2014-09-11 Secretion of heme-containing polypeptides WO2015038796A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US201361876676P true 2013-09-11 2013-09-11
US61/876,676 2013-09-11
US201361908689P true 2013-11-25 2013-11-25
US61/908,689 2013-11-25

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14844701.4A EP3044320A4 (en) 2013-09-11 2014-09-11 Secretion of heme-containing polypeptides
CN201480057829.3A CN105745332A (en) 2013-09-11 2014-09-11 Secretion of heme-containing polypeptides
US15/021,447 US20160340411A1 (en) 2013-01-11 2014-09-11 Secretion of heme-containing polypeptides
US15/672,466 US20170342131A1 (en) 2013-09-11 2017-08-09 Secretion of heme-containing polypeptides
US15/672,579 US20170342132A1 (en) 2013-09-11 2017-08-09 Secretion of heme-containing polypeptides

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US201615021447A A-371-Of-International 2016-03-11 2016-03-11
US15/672,466 Continuation US20170342131A1 (en) 2013-09-11 2017-08-09 Secretion of heme-containing polypeptides
US15/672,579 Continuation US20170342132A1 (en) 2013-09-11 2017-08-09 Secretion of heme-containing polypeptides

Publications (2)

Publication Number Publication Date
WO2015038796A2 WO2015038796A2 (en) 2015-03-19
WO2015038796A3 true WO2015038796A3 (en) 2015-10-29

Family

ID=52666512

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/055227 WO2015038796A2 (en) 2013-09-11 2014-09-11 Secretion of heme-containing polypeptides

Country Status (4)

Country Link
US (2) US20170342132A1 (en)
EP (1) EP3044320A4 (en)
CN (1) CN105745332A (en)
WO (1) WO2015038796A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
WO2018085693A1 (en) * 2016-11-04 2018-05-11 Inari Agriculture, Inc. Novel plant cells, plants, and seeds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080166757A1 (en) * 2000-09-18 2008-07-10 Sierd Bron Twin-arginine translocation in Bacillus
WO2012083424A1 (en) * 2010-12-21 2012-06-28 The University Of Western Ontario Novel amino acid linker sequences for ligand immobilization

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946587B1 (en) 1990-01-22 2005-09-20 Dekalb Genetics Corporation Method for preparing fertile transgenic corn plants
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
FR2736930B1 (en) * 1995-07-17 1997-09-19 Biocem Process for production by plant cells of protein heme, proteins thus obtained and products containing these proteins
US5959187A (en) * 1996-09-26 1999-09-28 Bailey; James E. Expression of oxygen-binding proteins in plants
JPH10117776A (en) 1996-10-22 1998-05-12 Japan Tobacco Inc Transformation of indica rice
US7807870B2 (en) * 2002-12-23 2010-10-05 Max-Planck-Gesellschaft Method for altering the content of reserve substances in plants
EP1651760A4 (en) * 2003-04-11 2006-10-18 Ventria Bioscience Human blood proteins expressed in monocot seeds
CA2897602A1 (en) 2013-01-11 2014-07-17 Impossible Foods Inc. Methods and compositions for consumables
KR20140047125A (en) * 2011-07-12 2014-04-21 마락시, 인크. Methods and compositions for consumables

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080166757A1 (en) * 2000-09-18 2008-07-10 Sierd Bron Twin-arginine translocation in Bacillus
WO2012083424A1 (en) * 2010-12-21 2012-06-28 The University Of Western Ontario Novel amino acid linker sequences for ligand immobilization

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LONDER ET AL.: "Production and preliminary characterization of a recombinant triheme cytochrome c(7) from Geobacter sulfurreducens in Escherichia coli.", BIOCHEM BIOPHYS ACTA, vol. 1554, no. 3, 1 July 2002 (2002-07-01), pages 202 - 211, XP 004373902, ISSN: 0005-2728 *
See also references of EP3044320A4 *
WU ET AL.: "Efficient production of a functional single-chain antidigoxin antibody via an engineered Bacillus subtilis expression-secretion system.", BIO/TECHNOLOGY ( NY, vol. 11, no. 1, January 1993 (1993-01-01), pages 71 - 76, XP055329301 *

Also Published As

Publication number Publication date
EP3044320A2 (en) 2016-07-20
WO2015038796A2 (en) 2015-03-19
US20170342132A1 (en) 2017-11-30
CN105745332A (en) 2016-07-06
EP3044320A4 (en) 2017-03-08
US20170342131A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
WO2014145490A3 (en) Breeding, production, processing and use of specialty cannabis
EP3071694A4 (en) Mutant cas9 proteins
EP3119393A4 (en) 5-substituted indazole-3-carboxamides and preparation and use thereof
HK1211866A1 (en) Antioxidant compositions and methods of using the same
WO2015153513A8 (en) Anti-ox40 antibodies and methods of use
EP3008168A4 (en) Sc- cells and compositions and methods for generating the same
EP3303379A4 (en) Tigit-binding agents and uses thereof
EP3364951A4 (en) Nicotine composition for vaping devices and vaping devices employing the same
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
EP3253890A4 (en) Tnfrsf-binding agents and uses thereof
WO2014152157A3 (en) Methods and compositions for the generation and use of conformation-specific antibodies
AU2019204981A1 (en) MK2 inhibitors and uses thereof
WO2015195531A3 (en) Syntac polypeptides and uses thereof
WO2015051030A8 (en) Stabilized polypeptides and uses thereof
EP3092256A4 (en) Compounds and compositions for immunotherapy
WO2016077381A8 (en) Anti-interleukin-33 antibodies and uses thereof
EP2968419A4 (en) Molded placental tissue compositions and methods of making and using the same
EP3303317A4 (en) Methods and compositions for inhibiting the interaction of menin with mll proteins
SG10201803042PA (en) Anti-tim-3 antibodies
EP3062796A4 (en) Compositions and methods for ophthalmic and/or other applications
IL247659D0 (en) Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof
AP201709771A0 (en) Carrier-antibody compositions and methods of making and using the same
EP3233052A4 (en) Suncare compositions and methods
EP3137505A4 (en) Combination of lenalidomide and polypeptide construct, and uses thereof
EP2981543A4 (en) Novel 4 7 peptide antagonists

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 15021447

Country of ref document: US

NENP Non-entry into the national phase in:

Ref country code: DE

REEP

Ref document number: 2014844701

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014844701

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14844701

Country of ref document: EP

Kind code of ref document: A2